Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Sales | 104,856 | 94,504 | 32,203 | 194,602 | 51,485 |
| Cost of Goods | 20,914 | 22,865 | 3,112 | 3,246 | 3,523 |
| Gross Profit | 83,942 | 71,639 | 29,091 | 191,356 | 47,962 |
| Operating Expenses | 81,621 | 89,718 | 39,052 | 33,777 | 31,785 |
| Operating Income | 3,235 | -17,214 | -9,849 | 157,825 | 16,700 |
| Interest Expense | 22,634 | 22,078 | 6,022 | -3,144 | 6,274 |
| Other Income | 62 | 61 | 57 | -9,122 | 23 |
| Pre-tax Income | -19,337 | -39,231 | -15,814 | 151,847 | 10,449 |
| Income Tax | -7,552 | -17,578 | -4,181 | 57,224 | 3,995 |
| Net Income Continuous | -11,785 | -21,653 | -11,633 | 94,623 | 6,454 |
| Net Income | $-11,785 | $-21,653 | $-11,633 | $94,623 | $6,454 |
| EPS Basic Total Ops | -0.80 | -1.44 | -0.80 | 6.48 | 0.44 |
| EPS Basic Continuous Ops | -0.78 | -1.44 | -0.78 | 6.48 | 0.44 |
| EPS Diluted Total Ops | -0.80 | -1.44 | -0.80 | 5.72 | 0.44 |
| EPS Diluted Continuous Ops | -0.78 | -1.44 | -0.78 | 5.48 | 0.42 |
| EBITDA(a) | $34,942 | $14,084 | $-3,468 | $163,900 | $20,580 |